E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice.
Jack L. Martin,Gang Jia,Seth S. Martin,Timothy Shapiro,Howard C. Herrmann,Peter M. DiBattiste,Eric J. Topol,David J. Moliterno +7 more
TL;DR: This work analyzed the relationship of obesity, determined by body mass index (BMI), to short‐ and long‐term outcomes in the TARGET trial to find out whether obesity can be controlled by diet, exercise, or both.
Journal ArticleDOI
The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular disease
Paddy M. Barrett,Eric J. Topol +1 more
TL;DR: Although an FBN-1 mutation does not guarantee the diagnosis of Marfan syndrome it is clear however that FBn-1 mutations independently confer additional risk for many of the cardiovascular complications classically associated with the disease.
Journal ArticleDOI
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: Effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide
David Hasdai,David R. Holmes,Douglas A. Criger,Eric J. Topol,Robert M. Califf,Robert G. Wilcox,Ernesto Paolasso,Maarten L. Simoons,Jaap G. Deckers,Robert A. Harrington +9 more
TL;DR: Among patients with ACS without persistent ST-segment elevation, cigarette smokers had better short-term outcomes because of their more favorable clinical profile and eptifibatide did not result in more improvement in their outcome compared with former smokers or nonsmokers.
Journal ArticleDOI
Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing.
Misha Angrist,Rodolphe Barrangou,Françoise Baylis,Carolyn Brokowski,Gaetan Burgio,Arthur L. Caplan,Carolyn Riley Chapman,George M. Church,Robert Cook-Deegan,Bryan Cwik,Jennifer A. Doudna,John H. Evans,Henry T. Greely,Laura Hercher,J. Benjamin Hurlbut,Richard O. Hynes,Tetsuya Ishii,Samira Kiani,Latasha Hoskins Lee,Guillaume Levrier,David R. Liu,Jeantine E. Lunshof,Kerry Lynn Macintosh,Debra J. H. Mathews,Eric M. Meslin,Peter Mills,Lluis Montoliu,Kiran Musunuru,Dianne Nicol,Helen O'Neill,Renzong Qiu,Robert Ranisch,Jacob S. Sherkow,Sheetal Soni,Sharon F. Terry,Eric J. Topol,Robert Williamson,Feng Zhang,Kevin A. Davies +38 more
TL;DR: Some three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.
Journal ArticleDOI
Medicine Unplugged: The Future of Laboratory Medicine
TL;DR: This work examines recent advancements in mobile diagnostics enabled by microfluidics and LOC technologies for POC clinical testing to create artificial-intelligence and decision support for patients and the medical community.